Tissue Factor Pathway Inhibitor-1 Is a Valuable Marker for the Prediction of Deep Venous Thrombosis and Tumor Metastasis in Patients with Lung Cancer

Table 4

Multivariate Logistic regression analysis of risk factors for tumor metastasis in NSCLC patients.

Variables	Partial regression coefficient	Standard error	Wald X^2	OR (95% CI)
TFPI-1	1.72	0.48	9.05	3.28 (2.12–10.98)	0.002
AT	1.40	0.40	7.55	3.00 (2.33–8.65)	0.012
Fbg	1.15	0.60	8.50	2.61 (1.31–8.31)	0.006
FVIII:C	0.90	0.55	6.01	2.02 (1.14–5.11)	0.023
D-D	0.77	0.33	11.39	1.25 (1.07–6.32)	<0.001

NSCLC: non-small cell lung cancer. TFPI-1: tissue factor pathway inhibitor-1. AT: antithrombin. Fbg: fibrinogen. FVIII:C: coagulating factor VIII procoagulant activity. D-D: D-dimer. OR: odds ratio. CI: confidence interval.